-- Nicotine-Free Tobacco-Free Smokeless Alternative to
Traditional Cigarettes
-- Simply Vitamins + Natural Flavors Conveniently
Vaporized by an eCig-like Device
-- Three Great Flavor Combinations: Relax, Refresh,
Energize
-- Additional Medical and Nutritional Applications In
the Pipeline
mCig, Inc. (OTCQB:MCIG) is pleased to announce that its wholly
owned subsidiary VitaCig, Inc. has officially launched its flagship
product: "VitaCig".
The VitaCig is an innovative $2 device that is nicotine-free and
smokeless. Instead of harmful toxins, the VitaCig emits flavorful
vapor comprised of vitamins, natural supplements, and organic
flavors. The VitaCig experience is unique and encompasses
everything you love (or loved) about smoking without the things you
don't. No tobacco smoke or cigarette smell. No more harmful tar,
and no nicotine, just vitamins + flavored vapor delivered in a
sleek metallic casing that looks and feels like an eCig.
The VitaCig comes in three great flavor combinations: Relax,
Refresh, and Energize. Order one today by visiting:
http://www.VitaCig.org.
VitaCig Video Ad
The company recently released a video advertisement for the
VitaCig which can be found here:
https://www.youtube.com/watch?v=tKaQcZ2r04I.
The Science Behind VitaCig*
The VitaCig device is designed to deliver vitamins and
phytonutrients via direct inhalation of rapidly absorbed vapor.
Phytonutrients are compounds found in plants that provide
significant health benefits. Every VitaCig includes the following
base Vitamins: A, B, C, E, and CoQ10 (Ubidecarenone).
RELAX
The "end of the day" VitaCig that can be enjoyed after a long
day at work or before bed-time. Extracts of blueberry and black
currant provide flavor as well as the potent anti-inflammatory and
antioxidant phytonutrients known as polyphenols and anthocyanins.
B-Myrcene belongs to a class of aromatic plant compounds called
monoterpenes and is incorporated for its sedative, muscle relaxant
and analgesic properties.
REFRESH
The "go-to" VitaCig that can be enjoyed throughout the day for a
refreshing and uplifting feeling. Oils of peppermint and spearmint
provide flavor and a natural source of menthol. Menthol, a
monterpene derivative, has analgesic, local anesthetic,
decongestant, expectorant and cooling properties. Eucalyptol
belongs to a class of aromatic plant compounds known as oxides and
has expectorant, decongestant, antiseptic, bronchodilatory and
cough suppressant properties.
ENERGIZE
The calorie-free "energy booster" that will help you get through
a slow day. Extracts of orange and grapefruit provide flavor,
vitamin C and citrus bioflavonoids. Citrus bioflavonoids have been
shown to provide antioxidant protection and immune system support.
Orange oil is added for flavor and as a natural source of limonene.
Limonene is a monoterpene incorporated for its stimulating,
uplifting, antiseptic, and anxiolytic properties.
* These statements have not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose, treat,
cure, or prevent any disease.
VitaCig and Future Electronic Cigarette
Regulation
VitaCig, Inc. management believes that the VitaCig should not be
classified as an electronic cigarette ("eCig"). With the exception
of certain design elements, the VitaCig bears little technical
resemblance to traditional nicotine-based eCigs. The VitaCig
delivers a vapor that contains a mix of natural flavors and
vitamins as opposed to nicotine, a regulated substance. The company
is closely monitoring regulatory developments within the Electronic
Cigarette Industry and is committed to operating with best industry
practices. More explicitly, if guidelines or regulations are
published that require standardization of components or testing for
electronic cigarette like devices, VitaCig will be the first to
abide by such regulations. In lieu of such guidelines, VitaCig is
proud to have its products manufactured in facilities that abide by
current globally accepted best industry standards such as:
Restriction of Hazardous Substance Directive (RoHS) and European CE
conformity marking.
VitaCig, Inc. Dividend and IPO
The VitaCig, Inc. Spin-Off, Dividend, and IPO remains on
schedule. The company will be filing the S1 Prospectus with the
Securities and Exchange Commission by April 20th, 2014.
About VitaCig, Inc. VitaCig, Inc. is a technology company that
is harnessing mobile vaporization technology for medical delivery
applications. The company has launched its first consumer
product: The VitaCig, a $2 nicotine-free device that looks and
feels like an electronic cigarette (eCig). Unlike a traditional
eCig, the VitaCig delivers a vapor of natural flavors, vitamins,
and phytonutrients. Initially the VitaCig will be produced in three
flavor categories: Relax, Refresh, Energize with plans for
additional flavor categories and targeted medical applications in
the future. The company is currently a subsidiary of mCig, Inc.
(Stock Symbol: MCIG) that is in the process of being spun-off to
shareholders.
The traditional tobacco industry is estimated at nearly $900
Billion a year. Financial analysts from Wells Fargo, Goldman Sachs,
and Citigroup predict that by 2022 Electronic Cigarettes will
supplant the traditional tobacco industry and eventually grow into
a $1 Trillion industry.
VitaCig is disrupting both the traditional tobacco industry and
the growing electronic cigarette industry by appealing to the
existing 1.2 Billion adults globally that smoke cigarettes,
providing them with a nicotine and tobacco-free alternative that
may assist in harm reduction. Moreover, the company is expanding
the target market beyond the 1.2 Billion adults by appealing to
non-smokers or occasional smokers with a superior method for the
consumption of Vitamins, Nutrients, and other compounds with
medicinal efficacy. – To learn more visit:
http://www.vitacig.org/investors/investor-opportunity-subpage/.
Safe Harbor Statement Any statements contained in this press
release that do not describe historical facts may constitute
forward-looking statements as that term is defined in the Private
Securities Litigation Reform Act of 1995. Any forward-looking
statements contained herein are based on current expectations, but
are subject to a number of risks and uncertainties. The factors
that could cause actual future results to differ materially from
current expectations include, but are not limited to, risks and
uncertainties relating to the Company's ability to develop, market
and sell products based on its technology; the expected benefits
and efficacy of the Company's products and technology; the
availability of substantial additional funding for the Company to
continue its operations and to conduct research and development,
and future product commercialization; and the Company's business,
research, product development, regulatory approval, marketing and
distribution plans and strategies.
CONTACT: Paul Rosenberg
CEO
(425)462-4219